Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

NCT03477175

Conditions
Solid Tumors
Locations
  • Harbor UCLA Medical Center Torrance, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • The Alfred Hospital Melbourne, Australia
View all 28 locations
View Trial Details
Completed

Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors

NCT02610361

Conditions
Solid Tumors
Locations
  • Chris Obrien Lifehouse Camperdown, New South Wales, Australia
  • North Coast Cancer Institute Macquarie, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
View all 19 locations
View Trial Details
Completed

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

NCT00828919

Conditions
Solid Tumors
Locations
  • UC Irvine Medical Center Orange, California, United States
  • University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA Hematology-Oncology-Santa Monica Santa Monica, California, United States
View all 34 locations
View Trial Details
Completed

Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer

NCT00909025

Conditions
Solid Tumors
Locations
  • Universitätsklinikum Essen, Innere Klinik (Tumorforschung) Essen, Germany
  • Universität Heidelberg, Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Germany
  • Johannes Gutenberg Universität, 1.Med Klinik und Poliklinik Mainz, Germany
  • Klinikum Rechts-der-Isar, III.Medizinische Klinik und Poliklinik München, Germany
View Trial Details
Completed

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

NCT00889382

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Department of Obstetrics and Gynecology, University of California, Irvine Orange, California, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 46 locations
View Trial Details
Completed

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

NCT02699515

Conditions
Solid Tumors
Locations
  • NHO Kyushu Cancer Center Fukuoka, Japan
  • National Cancer Center East, Department of Experimental Therapeutics Kashiwa, Japan
  • National Cancer Center East, Department of hepatobiliary and pancreatic oncology Kashiwa, Japan
  • Saitama Cancer Center Kitaadachi-gun, Japan
View all 18 locations
View Trial Details
Completed

An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors

NCT02038673

Conditions
Solid Tumors
Locations
  • Site US402 Orange, California, United States
  • Site US401 New York, United States
  • Site US404 Cleveland, Ohio, United States
  • Site US406 Spartanburg, South Carolina, United States
View all 35 locations
View Trial Details

Related conditions